VIPoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Clinical Trials

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
Conditions:   Neuroendocrine Tumors;   Carcinoid Tumor;   Pulmonary Carcinoid Tumor;   Gastroenteropancreatic Neuroendocrine Tumor;   Vipoma;   Insulinoma;   Gastrinoma Intervention:   Drug: 177Lu-DOTATOC Sponsor:   British Columbia Cancer Agency Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2021 Category: Research Source Type: clinical trials

DOTATOC PET/CT for Imaging NET Patients
Conditions:   Neuroendocrine Tumors;   Insulinoma;   Gastrinoma;   Glucagonoma;   Vipoma;   Pheochromocytoma;   Paraganglioma;   Neuroblastoma;   Ganglioneuroma;   Medullary Carcinoma;   Pituitary Adenoma;   Medulloblastoma;   Merkel Cell Carcinoma;   Small-cell Lung Cancer;   Meningioma;   Carcinoid Interventions:   Diagnostic Test: 68Ga-DOTATOC PET/CT;   Diagnostic Test: 18F-FDG PET/CT Sponsor:   British Columbia Cancer Agency Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2018 Category: Research Source Type: clinical trials